▶ 調査レポート

インフルエンザウイルスB感染薬のグローバル市場調査 2019年
• 英文タイトル：Global Influenzavirus B Infection Drug Market Professional Survey Report 2019

QYResearchが調査・発行した産業分析レポートです。インフルエンザウイルスB感染薬のグローバル市場調査 2019年 / Global Influenzavirus B Infection Drug Market Professional Survey Report 2019 / QYR9NV06786資料のイメージです。• レポートコード：QYR9NV06786
• 出版社/出版日：QYResearch / 2019年11月12日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、113ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・ヘルスケア
• 販売価格（消費税別）
  Single User￥518,000 (USD3,500)▷ お問い合わせ
  Enterprise License￥1,036,000 (USD7,000)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
※本調査レポートは、インフルエンザウイルスB感染薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、APP-309、CF-403、GC-3106A、KIN-1400、その他に、用途別には、クリニック、病院、その他にセグメント区分し、インフルエンザウイルスB感染薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・インフルエンザウイルスB感染薬の世界市場概要
・インフルエンザウイルスB感染薬の製造コスト構成分析
・インフルエンザウイルスB感染薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・インフルエンザウイルスB感染薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・インフルエンザウイルスB感染薬のセグメント分析（種類別）
（APP-309、CF-403、GC-3106A、KIN-1400、その他）
・インフルエンザウイルスB感染薬のセグメント分析（用途別）
（クリニック、病院、その他）
・インフルエンザウイルスB感染薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（AbbVie Inc、Adimmune Corp、Altravax Inc、Amarillo Biosciences Inc、Aphios Corp、BioCryst Pharmaceuticals Inc、Cadila Healthcare Ltd、ContraFect Corp、Daiichi Sankyo Company Ltd、Fujifilm Holdings Corporation、GlaxoSmithKline Plc、Green Cross Corp、Inovio Pharmaceuticals Inc、Kineta Inc、Medicago Inc、MedImmune LLC、Mucosis BV、Novavax Inc、Park Active Molecules、Romark Laboratories LC、）
・インフルエンザウイルスB感染薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

The global Influenzavirus B Infection Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Influenzavirus B Infection Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Influenzavirus B Infection Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Influenzavirus B Infection Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Influenzavirus B Infection Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AbbVie Inc
Adimmune Corp
Altravax Inc
Amarillo Biosciences Inc
Aphios Corp
BioCryst Pharmaceuticals Inc
Cadila Healthcare Ltd
ContraFect Corp
Daiichi Sankyo Company Ltd
Fujifilm Holdings Corporation
GlaxoSmithKline Plc
Green Cross Corp
Inovio Pharmaceuticals Inc
Kineta Inc
Medicago Inc
MedImmune LLC
Mucosis BV
Novavax Inc
Park Active Molecules
Romark Laboratories LC

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
APP-309
CF-403
GC-3106A
KIN-1400
Others

Segment by Application
Clinic
Hospital
Others

レポート目次

Table of Contents

Executive Summary
1 Industry Overview of Influenzavirus B Infection Drug
1.1 Definition of Influenzavirus B Infection Drug
1.2 Influenzavirus B Infection Drug Segment by Type
1.2.1 Global Influenzavirus B Infection Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 APP-309
1.2.3 CF-403
1.2.4 GC-3106A
1.2.5 KIN-1400
1.2.6 Others
1.3 Influenzavirus B Infection Drug Segment by Applications
1.3.1 Global Influenzavirus B Infection Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Influenzavirus B Infection Drug Overall Market
1.4.1 Global Influenzavirus B Infection Drug Revenue (2014-2025)
1.4.2 Global Influenzavirus B Infection Drug Production (2014-2025)
1.4.3 North America Influenzavirus B Infection Drug Status and Prospect (2014-2025)
1.4.4 Europe Influenzavirus B Infection Drug Status and Prospect (2014-2025)
1.4.5 China Influenzavirus B Infection Drug Status and Prospect (2014-2025)
1.4.6 Japan Influenzavirus B Infection Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Influenzavirus B Infection Drug Status and Prospect (2014-2025)
1.4.8 India Influenzavirus B Infection Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Influenzavirus B Infection Drug
2.3 Manufacturing Process Analysis of Influenzavirus B Infection Drug
2.4 Industry Chain Structure of Influenzavirus B Infection Drug

3 Development and Manufacturing Plants Analysis of Influenzavirus B Infection Drug
3.1 Capacity and Commercial Production Date
3.2 Global Influenzavirus B Infection Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Influenzavirus B Infection Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Influenzavirus B Infection Drug Production and Capacity Analysis
4.2 Influenzavirus B Infection Drug Revenue Analysis
4.3 Influenzavirus B Infection Drug Price Analysis
4.4 Market Concentration Degree

5 Influenzavirus B Infection Drug Regional Market Analysis
5.1 Influenzavirus B Infection Drug Production by Regions
5.1.1 Global Influenzavirus B Infection Drug Production by Regions
5.1.2 Global Influenzavirus B Infection Drug Revenue by Regions
5.2 Influenzavirus B Infection Drug Consumption by Regions
5.3 North America Influenzavirus B Infection Drug Market Analysis
5.3.1 North America Influenzavirus B Infection Drug Production
5.3.2 North America Influenzavirus B Infection Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Influenzavirus B Infection Drug Import and Export
5.4 Europe Influenzavirus B Infection Drug Market Analysis
5.4.1 Europe Influenzavirus B Infection Drug Production
5.4.2 Europe Influenzavirus B Infection Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Influenzavirus B Infection Drug Import and Export
5.5 China Influenzavirus B Infection Drug Market Analysis
5.5.1 China Influenzavirus B Infection Drug Production
5.5.2 China Influenzavirus B Infection Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Influenzavirus B Infection Drug Import and Export
5.6 Japan Influenzavirus B Infection Drug Market Analysis
5.6.1 Japan Influenzavirus B Infection Drug Production
5.6.2 Japan Influenzavirus B Infection Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Influenzavirus B Infection Drug Import and Export
5.7 Southeast Asia Influenzavirus B Infection Drug Market Analysis
5.7.1 Southeast Asia Influenzavirus B Infection Drug Production
5.7.2 Southeast Asia Influenzavirus B Infection Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Influenzavirus B Infection Drug Import and Export
5.8 India Influenzavirus B Infection Drug Market Analysis
5.8.1 India Influenzavirus B Infection Drug Production
5.8.2 India Influenzavirus B Infection Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Influenzavirus B Infection Drug Import and Export

6 Influenzavirus B Infection Drug Segment Market Analysis (by Type)
6.1 Global Influenzavirus B Infection Drug Production by Type
6.2 Global Influenzavirus B Infection Drug Revenue by Type
6.3 Influenzavirus B Infection Drug Price by Type

7 Influenzavirus B Infection Drug Segment Market Analysis (by Application)
7.1 Global Influenzavirus B Infection Drug Consumption by Application
7.2 Global Influenzavirus B Infection Drug Consumption Market Share by Application (2014-2019)

8 Influenzavirus B Infection Drug Major Manufacturers Analysis
8.1 AbbVie Inc
8.1.1 AbbVie Inc Influenzavirus B Infection Drug Production Sites and Area Served
8.1.2 AbbVie Inc Product Introduction, Application and Specification
8.1.3 AbbVie Inc Influenzavirus B Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Adimmune Corp
8.2.1 Adimmune Corp Influenzavirus B Infection Drug Production Sites and Area Served
8.2.2 Adimmune Corp Product Introduction, Application and Specification
8.2.3 Adimmune Corp Influenzavirus B Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Altravax Inc
8.3.1 Altravax Inc Influenzavirus B Infection Drug Production Sites and Area Served
8.3.2 Altravax Inc Product Introduction, Application and Specification
8.3.3 Altravax Inc Influenzavirus B Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Amarillo Biosciences Inc
8.4.1 Amarillo Biosciences Inc Influenzavirus B Infection Drug Production Sites and Area Served
8.4.2 Amarillo Biosciences Inc Product Introduction, Application and Specification
8.4.3 Amarillo Biosciences Inc Influenzavirus B Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Aphios Corp
8.5.1 Aphios Corp Influenzavirus B Infection Drug Production Sites and Area Served
8.5.2 Aphios Corp Product Introduction, Application and Specification
8.5.3 Aphios Corp Influenzavirus B Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 BioCryst Pharmaceuticals Inc
8.6.1 BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Production Sites and Area Served
8.6.2 BioCryst Pharmaceuticals Inc Product Introduction, Application and Specification
8.6.3 BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Cadila Healthcare Ltd
8.7.1 Cadila Healthcare Ltd Influenzavirus B Infection Drug Production Sites and Area Served
8.7.2 Cadila Healthcare Ltd Product Introduction, Application and Specification
8.7.3 Cadila Healthcare Ltd Influenzavirus B Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 ContraFect Corp
8.8.1 ContraFect Corp Influenzavirus B Infection Drug Production Sites and Area Served
8.8.2 ContraFect Corp Product Introduction, Application and Specification
8.8.3 ContraFect Corp Influenzavirus B Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Daiichi Sankyo Company Ltd
8.9.1 Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Production Sites and Area Served
8.9.2 Daiichi Sankyo Company Ltd Product Introduction, Application and Specification
8.9.3 Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Fujifilm Holdings Corporation
8.10.1 Fujifilm Holdings Corporation Influenzavirus B Infection Drug Production Sites and Area Served
8.10.2 Fujifilm Holdings Corporation Product Introduction, Application and Specification
8.10.3 Fujifilm Holdings Corporation Influenzavirus B Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 GlaxoSmithKline Plc
8.12 Green Cross Corp
8.13 Inovio Pharmaceuticals Inc
8.14 Kineta Inc
8.15 Medicago Inc
8.16 MedImmune LLC
8.17 Mucosis BV
8.18 Novavax Inc
8.19 Park Active Molecules
8.20 Romark Laboratories LC

9 Development Trend of Analysis of Influenzavirus B Infection Drug Market
9.1 Global Influenzavirus B Infection Drug Market Trend Analysis
9.1.1 Global Influenzavirus B Infection Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Influenzavirus B Infection Drug Regional Market Trend
9.2.1 North America Influenzavirus B Infection Drug Forecast 2019-2025
9.2.2 Europe Influenzavirus B Infection Drug Forecast 2019-2025
9.2.3 China Influenzavirus B Infection Drug Forecast 2019-2025
9.2.4 Japan Influenzavirus B Infection Drug Forecast 2019-2025
9.2.5 Southeast Asia Influenzavirus B Infection Drug Forecast 2019-2025
9.2.6 India Influenzavirus B Infection Drug Forecast 2019-2025
9.3 Influenzavirus B Infection Drug Market Trend (Product Type)
9.4 Influenzavirus B Infection Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Influenzavirus B Infection Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Influenzavirus B Infection Drug
Table Global Influenzavirus B Infection Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Influenzavirus B Infection Drug Production Market Share by Types in 2018
Figure APP-309 Product Picture
Figure CF-403 Product Picture
Figure GC-3106A Product Picture
Figure KIN-1400 Product Picture
Figure Others Product Picture
Table Global Influenzavirus B Infection Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Influenzavirus B Infection Drug Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Others
Figure Global Influenzavirus B Infection Drug Revenue (Million USD) (2014-2025)
Figure Global Influenzavirus B Infection Drug Production (K Pcs) (2014-2025)
Figure North America Influenzavirus B Infection Drug Market Size (Million USD) (2014-2025)
Figure Europe Influenzavirus B Infection Drug Market Size (Million USD) (2014-2025)
Figure China Influenzavirus B Infection Drug Market Size (Million USD) (2014-2025)
Figure Japan Influenzavirus B Infection Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Influenzavirus B Infection Drug Market Size (Million USD) (2014-2025)
Figure India Influenzavirus B Infection Drug Market Size (Million USD) (2014-2025)
Table Influenzavirus B Infection Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Influenzavirus B Infection Drug in 2018
Figure Manufacturing Process Analysis of Influenzavirus B Infection Drug
Figure Industry Chain Structure of Influenzavirus B Infection Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Influenzavirus B Infection Drug Manufacturing Plants Distribution
Table Influenzavirus B Infection Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Influenzavirus B Infection Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Influenzavirus B Infection Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Influenzavirus B Infection Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Influenzavirus B Infection Drug Production Share by Manufacturers in 2018
Table Influenzavirus B Infection Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Influenzavirus B Infection Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Influenzavirus B Infection Drug Revenue Share by Manufacturers in 2018
Table Influenzavirus B Infection Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Influenzavirus B Infection Drug Production by Regions 2014-2019 (K Pcs)
Table Global Influenzavirus B Infection Drug Production Market Share by Regions 2014-2019
Figure Global Influenzavirus B Infection Drug Production Market Share by Regions in 2018
Table Global Influenzavirus B Infection Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Influenzavirus B Infection Drug Revenue Market Share by Regions 2014-2019
Figure Global Influenzavirus B Infection Drug Revenue Market Share by Regions in 2018
Table Global Influenzavirus B Infection Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Influenzavirus B Infection Drug Consumption Market Share by Regions 2014-2019
Figure North America Influenzavirus B Infection Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Influenzavirus B Infection Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Influenzavirus B Infection Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Influenzavirus B Infection Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Influenzavirus B Infection Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Influenzavirus B Infection Drug Production, Consumption Import and Export (K Pcs)
Figure China Influenzavirus B Infection Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Influenzavirus B Infection Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Influenzavirus B Infection Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Influenzavirus B Infection Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Influenzavirus B Infection Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Influenzavirus B Infection Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Influenzavirus B Infection Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Influenzavirus B Infection Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Influenzavirus B Infection Drug Production, Consumption Import and Export (K Pcs)
Figure India Influenzavirus B Infection Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Influenzavirus B Infection Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Influenzavirus B Infection Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Influenzavirus B Infection Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Influenzavirus B Infection Drug Market Share by Application (2014-2019)
Table AbbVie Inc Influenzavirus B Infection Drug Production Sites and Area Served
Table AbbVie Inc Influenzavirus B Infection Drug Product Introduction, Application and Specification
Table AbbVie Inc Influenzavirus B Infection Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AbbVie Inc Influenzavirus B Infection Drug Production Growth Rate (2014-2019)
Table AbbVie Inc Influenzavirus B Infection Drug Production Market Share (2014-2019)
Figure AbbVie Inc Influenzavirus B Infection Drug Revenue Market Share (2014-2019)
Table AbbVie Inc Influenzavirus B Infection Drug Main Business and Markets Served
Table Adimmune Corp Influenzavirus B Infection Drug Production Sites and Area Served
Table Adimmune Corp Influenzavirus B Infection Drug Product Introduction, Application and Specification
Table Adimmune Corp Influenzavirus B Infection Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Adimmune Corp Influenzavirus B Infection Drug Production Growth Rate (2014-2019)
Table Adimmune Corp Influenzavirus B Infection Drug Production Market Share (2014-2019)
Figure Adimmune Corp Influenzavirus B Infection Drug Revenue Market Share (2014-2019)
Table Adimmune Corp Influenzavirus B Infection Drug Main Business and Markets Served
Table Altravax Inc Influenzavirus B Infection Drug Production Sites and Area Served
Table Altravax Inc Influenzavirus B Infection Drug Product Introduction, Application and Specification
Table Altravax Inc Influenzavirus B Infection Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Altravax Inc Influenzavirus B Infection Drug Production Growth Rate (2014-2019)
Table Altravax Inc Influenzavirus B Infection Drug Production Market Share (2014-2019)
Figure Altravax Inc Influenzavirus B Infection Drug Revenue Market Share (2014-2019)
Table Altravax Inc Influenzavirus B Infection Drug Main Business and Markets Served
Table Amarillo Biosciences Inc Influenzavirus B Infection Drug Production Sites and Area Served
Table Amarillo Biosciences Inc Influenzavirus B Infection Drug Product Introduction, Application and Specification
Table Amarillo Biosciences Inc Influenzavirus B Infection Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Amarillo Biosciences Inc Influenzavirus B Infection Drug Production Growth Rate (2014-2019)
Table Amarillo Biosciences Inc Influenzavirus B Infection Drug Production Market Share (2014-2019)
Figure Amarillo Biosciences Inc Influenzavirus B Infection Drug Revenue Market Share (2014-2019)
Table Amarillo Biosciences Inc Influenzavirus B Infection Drug Main Business and Markets Served
Table Aphios Corp Influenzavirus B Infection Drug Production Sites and Area Served
Table Aphios Corp Influenzavirus B Infection Drug Product Introduction, Application and Specification
Table Aphios Corp Influenzavirus B Infection Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Aphios Corp Influenzavirus B Infection Drug Production Growth Rate (2014-2019)
Table Aphios Corp Influenzavirus B Infection Drug Production Market Share (2014-2019)
Figure Aphios Corp Influenzavirus B Infection Drug Revenue Market Share (2014-2019)
Table Aphios Corp Influenzavirus B Infection Drug Main Business and Markets Served
Table BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Production Sites and Area Served
Table BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Product Introduction, Application and Specification
Table BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Production Growth Rate (2014-2019)
Table BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Production Market Share (2014-2019)
Figure BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Revenue Market Share (2014-2019)
Table BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Main Business and Markets Served
Table Cadila Healthcare Ltd Influenzavirus B Infection Drug Production Sites and Area Served
Table Cadila Healthcare Ltd Influenzavirus B Infection Drug Product Introduction, Application and Specification
Table Cadila Healthcare Ltd Influenzavirus B Infection Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cadila Healthcare Ltd Influenzavirus B Infection Drug Production Growth Rate (2014-2019)
Table Cadila Healthcare Ltd Influenzavirus B Infection Drug Production Market Share (2014-2019)
Figure Cadila Healthcare Ltd Influenzavirus B Infection Drug Revenue Market Share (2014-2019)
Table Cadila Healthcare Ltd Influenzavirus B Infection Drug Main Business and Markets Served
Table ContraFect Corp Influenzavirus B Infection Drug Production Sites and Area Served
Table ContraFect Corp Influenzavirus B Infection Drug Product Introduction, Application and Specification
Table ContraFect Corp Influenzavirus B Infection Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table ContraFect Corp Influenzavirus B Infection Drug Production Growth Rate (2014-2019)
Table ContraFect Corp Influenzavirus B Infection Drug Production Market Share (2014-2019)
Figure ContraFect Corp Influenzavirus B Infection Drug Revenue Market Share (2014-2019)
Table ContraFect Corp Influenzavirus B Infection Drug Main Business and Markets Served
Table Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Production Sites and Area Served
Table Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Product Introduction, Application and Specification
Table Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Production Growth Rate (2014-2019)
Table Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Production Market Share (2014-2019)
Figure Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Revenue Market Share (2014-2019)
Table Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Main Business and Markets Served
Table Fujifilm Holdings Corporation Influenzavirus B Infection Drug Production Sites and Area Served
Table Fujifilm Holdings Corporation Influenzavirus B Infection Drug Product Introduction, Application and Specification
Table Fujifilm Holdings Corporation Influenzavirus B Infection Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Fujifilm Holdings Corporation Influenzavirus B Infection Drug Production Growth Rate (2014-2019)
Table Fujifilm Holdings Corporation Influenzavirus B Infection Drug Production Market Share (2014-2019)
Figure Fujifilm Holdings Corporation Influenzavirus B Infection Drug Revenue Market Share (2014-2019)
Table Fujifilm Holdings Corporation Influenzavirus B Infection Drug Main Business and Markets Served
Table GlaxoSmithKline Plc Influenzavirus B Infection Drug Production Sites and Area Served
Table Green Cross Corp Influenzavirus B Infection Drug Production Sites and Area Served
Table Inovio Pharmaceuticals Inc Influenzavirus B Infection Drug Production Sites and Area Served
Table Kineta Inc Influenzavirus B Infection Drug Production Sites and Area Served
Table Medicago Inc Influenzavirus B Infection Drug Production Sites and Area Served
Table MedImmune LLC Influenzavirus B Infection Drug Production Sites and Area Served
Table Mucosis BV Influenzavirus B Infection Drug Production Sites and Area Served
Table Novavax Inc Influenzavirus B Infection Drug Production Sites and Area Served
Table Park Active Molecules Influenzavirus B Infection Drug Production Sites and Area Served
Table Romark Laboratories LC Influenzavirus B Infection Drug Production Sites and Area Served
Figure Global Influenzavirus B Infection Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Influenzavirus B Infection Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Influenzavirus B Infection Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Influenzavirus B Infection Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Influenzavirus B Infection Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Influenzavirus B Infection Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Influenzavirus B Infection Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Influenzavirus B Infection Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Influenzavirus B Infection Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Influenzavirus B Infection Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Influenzavirus B Infection Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Influenzavirus B Infection Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Influenzavirus B Infection Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Influenzavirus B Infection Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Influenzavirus B Infection Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Influenzavirus B Infection Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Influenzavirus B Infection Drug by Application (2019-2025)
Table Influenzavirus B Infection Drug Distributors List
Table Influenzavirus B Infection Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • グラム陰性菌感染症治療薬のグローバル市場：規模・現状・予測2019-2025
    Global Gram-Negative Bacterial Infection Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9NV17975 2019年11月18日 91Pages
    ※当調査レポートでは、グラム陰性菌感染症治療薬の世界市場について調査・分析し、グラム陰性菌感染症治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（経腸治療、非経口治療、局所治療）、用途別（病院、...
  • 緑膿菌感染症治療のグローバル市場：規模・現状・予測2019-2025
    Global Pseudomonas Aeruginosa Infection Treatment Market Size, Status and Forecast 2019-2025
    QYR9NV18332 2019年11月18日 90Pages
    ※当調査レポートでは、緑膿菌感染症治療の世界市場について調査・分析し、緑膿菌感染症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（鼻、経口、静脈内）、用途別（病院薬局、小売薬局、オンライン薬局）...
  • グラム陰性菌感染症治療薬のグローバル市場：規模・現状・予測2019-2025
    Global Gram-Negative Bacterial Infection Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9NV17975 2019年11月18日 91Pages
    ※当調査レポートでは、グラム陰性菌感染症治療薬の世界市場について調査・分析し、グラム陰性菌感染症治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（経腸治療、非経口治療、局所治療）、用途別（病院、...
  • 潜在性結核感染（LTBI）検査のグローバル市場：規模・現状・予測2019-2025
    Global Latent Tuberculosis Infection (LTBI) Testing Market Size, Status and Forecast 2019-2025
    QYR9NV18079 2019年11月18日 90Pages
    ※当調査レポートでは、潜在性結核感染（LTBI）検査の世界市場について調査・分析し、潜在性結核感染（LTBI）検査の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ツベルクリン皮膚試験（TST）、イン...
  • 潜在性結核感染（LTBI）検査のグローバル市場：規模・現状・予測2019-2025
    Global Latent Tuberculosis Infection (LTBI) Testing Market Size, Status and Forecast 2019-2025
    QYR9NV18079 2019年11月18日 90Pages
    ※当調査レポートでは、潜在性結核感染（LTBI）検査の世界市場について調査・分析し、潜在性結核感染（LTBI）検査の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ツベルクリン皮膚試験（TST）、イン...
  • マールブルクウイルス感染のグローバル市場調査 2019年
    Global Marburgvirus Infection Market Professional Survey Report 2019
    QYR9NV07930 2019年11月14日 111Pages
    ※本調査レポートは、マールブルクウイルス感染の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エリトラン四ナトリウム、AR-12、ARD-5、AVI-7288、...
  • 尿路感染症治療薬のグローバル市場調査 2019年
    Global Urinary Tract Infection Therapeutics Market Professional Survey Report 2019
    QYR9NV13959 2019年11月16日 100Pages
    ※本調査レポートは、尿路感染症治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、キノロン、ペニシリン組み合わせ、セファロスポリン、テトラサイクリン、スルホ...
  • 尿路感染症治療薬のグローバル市場調査 2019年
    Global Urinary Tract Infection Therapeutics Market Professional Survey Report 2019
    QYR9NV13959 2019年11月16日 100Pages
    ※本調査レポートは、尿路感染症治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、キノロン、ペニシリン組み合わせ、セファロスポリン、テトラサイクリン、スルホ...
  • クラミジア感染検査のグローバル市場調査 2019年
    Global Chlamydia Infection Test Market Professional Survey Report 2019
    QYR9NV02529 2019年11月12日 111Pages
    ※本調査レポートは、クラミジア感染検査の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、核酸増幅試験（NAAT）、直接蛍光試験に、用途別には、病院、商業/民間研...
  • 世界及び中国のH5N1感染薬市場2018世界及び中国のH5N1感染薬市場2018 The 'Global and Chinese H5N1 Infection Drug Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global H5N1 Infection Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the H5N1 Infecti…
  • 世界及び中国の全身感染症治療市場2018世界及び中国の全身感染症治療市場2018 The 'Global and Chinese Systemic Infection Treatment Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Systemic Infection Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status o…
  • 世界及び中国の歯科感染制御製品市場2018世界及び中国の歯科感染制御製品市場2018 The 'Global and Chinese Dental Infection Control Product Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Dental Infection Control Product industry with a focus on the Chinese market. The report provides key statistics on the market …
  • グラム陰性菌感染症治療薬のグローバル市場：規模・現状・予測2019-2025グラム陰性菌感染症治療薬のグローバル市場：規模・現状・予測2019-2025 Gram-negative bacteria generally refer to bacteria that show red in the gram-negative staining reaction.In 2018, the global Gram-Negative Bacterial Infection Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025…
  • グラム陰性菌感染症治療薬のグローバル市場：規模・現状・予測2019-2025グラム陰性菌感染症治療薬のグローバル市場：規模・現状・予測2019-2025 Gram-negative bacteria generally refer to bacteria that show red in the gram-negative staining reaction.In 2018, the global Gram-Negative Bacterial Infection Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025…